News

Researchers have developed a potential diagnostic that can identify patients with high-grade serous ovarian cancer who won’t benefit from standard treatment.

A new study from Duke University has called into question the theory that a species of fungus may fuel pancreatic cancer, finding no link between the pancreatic microbiome and cancer development.

New research has uncovered evidence that the thymus is in fact critical for adult health generally and for preventing cancer and perhaps autoimmune disease.

Scientists have developed a nanoengineered bioink with improved bonding and cross-linking capabilities for 3D bioprinting of tumor models.

A new study has illustrated that patients with a high BMI are at higher risk of heart damage during cancer treatment.

Short pieces of DNA floating in the bloodstream of cancer patients can help doctors diagnose specific types of cancer and choose the most effective treatment.

A research group has characterized the cellular composition and spatial architecture of the tumor microenvironment in human multiple primary lung cancers by integrating single-cell RNA-seq and spatial transcriptomics.

In a landmark study of 125 Australian children with high-risk cancer, researchers have found that they can improve the chances of finding the right drug to kill their individual cancer through a new system of rapid drug screening.

According to a study, cancer research centers conducting clinical trials could enroll more patients from underrepresented racial and ethnic groups by placing greater emphasis on relieving investigators of the costs of translating consent documents.

Researchers discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies.